W ithin a month after the first case was reported on February 2020 in Brazil, all countries in Latin America had reported cases of the novel coronavirus disease 2019 (COVID-19); Brazil, Argentina, and Colombia were the most affected countries, with 9,467,320 cases among them reported by early December. 1 Increased poverty, limited water access, poor sanitation, and distrust in governments are important factors that have affected the transmission and have facilitated COVID-19 outbreaks in Latin America. 2 Acute kidney injury (AKI) is common among critically ill patients with COVID-19, affecting approximately 20% to 40% of patients admitted to intensive care units; unfortunately, the overall burden of AKI in COVID-19 might be underestimated in Latin America. Available information on epidemiology and risk factors for AKI in the region is generally scarce, and this situation has not improved during the COVID-19 pandemic. A recent study from 15 countries in Latin America, the "Estudio Epidemiológico Longitudinal de Injuria Renal Aguda" (EPILAT-IRA), provided data on 905 patients with AKI; the median age was 64 (range, 50-74) years, and 61% were male. AKI was community acquired in 62% of patients, with dehydration, shock, and nephrotoxic drugs being the most common causes. Renal replacement therapy (RRT) was performed in 29% of cases, and the incidence of all-cause in-hospital mortality was 26.5%. 3 Preliminary and unpublished data from the Latin American Society of Nephrology and Hypertension AKI Committee registry of AKI in COVID-19 patients, which has enrolled 393 subjects so far, showed that >50% of patients were female, the median age was 60 (interquartile range, 48-71) years, 36% of patients developed proteinuria, and 17% presented with hematuria. Most of the AKI was hospital acquired (66%), and 225 of the 393 patients (57.2%) had indications for starting